
Europe's drug makers have warned about stopping manufacturing some cheap generic medicines amid surging electricity costs.
You can purchase shares of FRESENIUS SE S/ADR by Fresenius SE & Co. KGaA (OTCPK:FSNUY) through any online brokerage.
There are no as such competitors for FRESENIUS SE S/ADR by Fresenius SE & Co. KGaA.
There is no analysis for FRESENIUS SE S/ADR by Fresenius SE & Co. KGaA to provide a consensus price target.
The stock price for FRESENIUS SE S/ADR by Fresenius SE & Co. KGaA (OTCPK: FSNUY) is $12.88 last updated October 23, 2026 at 3:59 PM EDT.
There are no upcoming dividends for FRESENIUS SE S/ADR by Fresenius SE & Co. KGaA.
FRESENIUS SE S/ADR by Fresenius SE & Co. KGaA does not have any upcoming earnings scheduled.
There is no upcoming split for FRESENIUS SE S/ADR by Fresenius SE & Co. KGaA.
FRESENIUS SE S/ADR by Fresenius SE & Co. KGaA is in the Health Care sector and Health Care Providers & Services industry. They are listed on the OTCPK.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products,...